Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Haematologica|July 17, 2025
Fit, unfit, or frail? Now easier to tell for Hodgkin lymphomaAlison J MoskowitzJournal of Oncology Practice|March 13, 2019
Practical Treatment Approach for Angioimmunoblastic T-Cell LymphomaAlison J MoskowitzHaematologica|April 2, 2026
Relapsed Hodgkin disease: Should all patients receive an autologous stem cell transplant? - the CONAlison J MoskowitzHematology. American Society of Hematology. Education Program|December 9, 2022
Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?Alison J MoskowitzHematology. American Society of Hematology. Education Program|December 4, 2018
Optimizing the role of brentuximab vedotin in classical Hodgkin lymphoma therapyAlison J MoskowitzCurrent Hematologic Malignancy Reports|May 11, 2017
Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?Niloufer Khan, Alison J MoskowitzCancers|February 11, 2023
Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell LymphomaRobert Stuver, Alison J MoskowitzCurrent Opinion in Oncology|July 15, 2024
What is the best salvage therapy for Hodgkin lymphoma?Efrat Luttwak, Alison J MoskowitzPageof 11